In the week of July 20, 2026, 13 holders filed a new Schedule 13D and 67 a new Schedule 13G reporting 5% or more of a company. The largest stake reported that week is Paolo Tiramani's 94.8% of FG Merger II Corp. (Schedule 13D, July 24, 2026).
The week of 2026-07-20, 13 holders filed a new Schedule 13D and 67 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-07-24 | FG Merger II Corp. | Paolo Tiramani | 94.8% | SCHEDULE 13D |
| 2026-07-24 | FG Merger II Corp. | Galiano Paolo Tiramani | 86.5% | SCHEDULE 13D |
| 2026-07-24 | Nex Neo Tech Inc. | Dzieszuta Katarzyna | 54.6% | SCHEDULE 13D |
| 2026-07-24 | Niki BioSolutions, Inc. | Kira S. Sheinerman | 51.56% | SCHEDULE 13D |
| 2026-07-20 | SPAR Group, Inc. | ReposiTrak, Inc. | 31.4% | SCHEDULE 13D |
| 2026-07-23 | HST Global, Inc. | Field Michael L | 31% | SCHEDULE 13D |
| 2026-07-24 | Karbon Capital Partners Corp. | Karbon Capital Partners Core Holdings, LLC | 21.6% | SCHEDULE 13D |
| 2026-07-20 | Costamare Bulkers Holdings Limited | Achillefs Konstantakopoulos | 20.5% | SCHEDULE 13D |
| 2026-07-23 | SenesTech, Inc. | Glenbrook Capital Management | 19.95% | SCHEDULE 13D |
| 2026-07-21 | Research Alliance Corporation IV | Research Alliance Holdings IV LLC | 17% | SCHEDULE 13D |
| 2026-07-24 | T3 Defense Inc. | Elad Shohat | 16.67% | SCHEDULE 13D |
| 2026-07-24 | Telos Corp | John B. Wood | 9.1% | SCHEDULE 13D |
| 2026-07-23 | Metals Royalty Co Inc. | Michael Bernard Hess | 5.55% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-07-20 | Margaree Acquisition Corp. | Mark N. Tompkins | 75% | SCHEDULE 13G |
| 2026-07-21 | RTB Digital, Inc. | Dorsett Jason Christopher | 30.6% | SCHEDULE 13G |
| 2026-07-20 | Margaree Acquisition Corp. | Ian S. Jacobs | 25% | SCHEDULE 13G |
| 2026-07-23 | Standard Nuclear, Inc. | Decisive Point Group, LLC | 17.83% | SCHEDULE 13G |
| 2026-07-21 | Qumulusai, Inc. | Bissell Robert Christopher | 17.8% | SCHEDULE 13G |
| 2026-07-24 | Nauticus Robotics, Inc. | Rcb Equities 1, LLC | 11.4% | SCHEDULE 13G |
| 2026-07-23 | Freenome, Inc. | Perceptive Advisors LLC | 10.1% | SCHEDULE 13G |
| 2026-07-20 | Nuvve Holding Corp. | The Hewlett Fund LP | 9.99% | SCHEDULE 13G |
| 2026-07-22 | Nuvve Holding Corp. | RainForest Partners, LLC | 9.99% | SCHEDULE 13G |
| 2026-07-20 | Agenus Inc | RA Capital Management, L.P. | 9.9% | SCHEDULE 13G |
| 2026-07-20 | Chain Bridge Bancorp Inc | Hingham Institution for Savings | 9.9% | SCHEDULE 13G |
| 2026-07-21 | AEON Biopharma, Inc. | Stonepine Capital Management, LLC | 9.9% | SCHEDULE 13G |
| 2026-07-23 | Nuburu, Inc. | Esousa Group Holdings LLC | 9.9% | SCHEDULE 13G |
| 2026-07-23 | Taoping Inc. | Streeterville Capital LLC | 9.9% | SCHEDULE 13G |
| 2026-07-20 | Catheter Precision, Inc. | Seg Jets Spv I, LLC | 9.79% | SCHEDULE 13G |
| 2026-07-24 | Realloys Inc. | Andrew Sherman | 9.44% | SCHEDULE 13G |
| 2026-07-20 | Nebius Group N.V. | NVIDIA Corporation | 9.3% | SCHEDULE 13G |
| 2026-07-23 | LanzaTech Global, Inc. | Tindall Stephen Robert | 9.3% | SCHEDULE 13G |
| 2026-07-22 | Nuburu, Inc. | Avondale Capital, LLC | 8.8% | SCHEDULE 13G |
| 2026-07-20 | ClearThink 1 Acquisition Corp. | Mangrove Partners IM, LLC | 8.43% | SCHEDULE 13G |
| 2026-07-20 | Fermi Inc. | Caddis Holdings, LP | 8.2% | SCHEDULE 13G |
| 2026-07-20 | ITG, Inc. | Ophir Asset Management Pty Ltd | 7.9% | SCHEDULE 13G |
| 2026-07-24 | Ionetix Corp / DE / | ELI LILLY & Co | 7.9% | SCHEDULE 13G |
| 2026-07-22 | Commercial Vehicle Group, Inc. | The TCW Group, Inc., on behalf of the TCW Business Unit | 7.84% | SCHEDULE 13G |
| 2026-07-20 | Research Alliance Corporation IV | Perceptive Advisors LLC | 7.7% | SCHEDULE 13G |
| 2026-07-22 | Masterbrand Inc | Pzena Investment Management LLC | 7.5% | SCHEDULE 13G |
| 2026-07-21 | SuperX AI Technology Ltd | Mercuria Holdings (Singapore) Pte. Ltd. | 7.1% | SCHEDULE 13G |
| 2026-07-22 | HeartCore Enterprises, Inc. | Hnatko Capital Inc. | 7.1% | SCHEDULE 13G |
| 2026-07-24 | Ionic Digital Inc. | Sachem Head Capital Management LP | 6.9% | SCHEDULE 13G |
| 2026-07-24 | Beta Bionics, Inc. | Divisadero Street Capital Management, LP | 6.9% | SCHEDULE 13G |
| 2026-07-23 | WhiteHawk Minerals Corp. | Horizon Kinetics Asset Management LLC | 6.8% | SCHEDULE 13G |
| 2026-07-20 | Conexeu Sciences Inc. | Paisley Capital Holdings Corp | 6.7% | SCHEDULE 13G |
| 2026-07-23 | Mbia Inc | Leeam S. Lowin | 6.5% | SCHEDULE 13G |
| 2026-07-23 | Rare Earths Americas, Inc. | Allen Dominic Paul | 6.5% | SCHEDULE 13G |
| 2026-07-20 | Research Alliance Corporation IV | Bvf Partners L P | 6.4% | SCHEDULE 13G |
| 2026-07-22 | Southern Cross Acquisition I Corp. | Space Summit Capital LLC | 6.4% | SCHEDULE 13G |
| 2026-07-21 | CPI Aerostructures, Inc. | Royce & Associates LP | 6.33% | SCHEDULE 13G |
| 2026-07-20 | DarkHorse Technologies Inc. | Jialin Qu | 6.2% | SCHEDULE 13G |
| 2026-07-24 | General Fusion Group Ltd. | BDC Capital Inc. | 6.2% | SCHEDULE 13G |
| 2026-07-22 | Inseego Corp | Royce & Associates LP | 6.13% | SCHEDULE 13G |
| 2026-07-22 | OptimizeRx Corp | Royce & Associates LP | 5.81% | SCHEDULE 13G |
| 2026-07-20 | Alto Neuroscience Inc | EcoR1 Capital, LLC | 5.8% | SCHEDULE 13G |
| 2026-07-22 | FTAI Aviation Ltd. | Shikiar Asset Management Inc | 5.8% | SCHEDULE 13G |
| 2026-07-21 | SOBR Safe, Inc. | Mitchell P. Kopin | 5.6% | SCHEDULE 13G |
| 2026-07-21 | Plum Acquisition Corp | Context Capital Management, LLC | 5.6% | SCHEDULE 13G |
| 2026-07-21 | Manchester United plc | Boldhaven Management LLP | 5.6% | SCHEDULE 13G |
| 2026-07-20 | Research Alliance Corporation IV | Commodore Capital LP | 5.5% | SCHEDULE 13G |
| 2026-07-21 | Research Alliance Corporation IV | Trails Edge Capital Partners, LP | 5.5% | SCHEDULE 13G |
| 2026-07-22 | Ranger Energy Services, Inc. | Royce & Associates LP | 5.46% | SCHEDULE 13G |
| 2026-07-20 | Precision BioSciences, Inc. | Lynx1 Capital Management LP | 5.4% | SCHEDULE 13G |
| 2026-07-21 | Health Catalyst, Inc. | Impax Asset Management Group plc | 5.4% | SCHEDULE 13G |
| 2026-07-24 | Bowhead Specialty Holdings Inc | Victory Capital Management, Inc. | 5.39% | SCHEDULE 13G |
| 2026-07-20 | New ERA Energy & Digital, Inc. | Conversant Capital LLC | 5.3% | SCHEDULE 13G |
| 2026-07-20 | Perspective Therapeutics, Inc. | Millennium Management LLC | 5.3% | SCHEDULE 13G |
| 2026-07-21 | GXO Logistics, Inc. | Spruce House Investment Management LLC | 5.2% | SCHEDULE 13G |
| 2026-07-22 | Ameresco, Inc. | Millennium Management LLC | 5.2% | SCHEDULE 13G |
| 2026-07-22 | Ch4 Natural Solutions Corporation | RP Investment Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-07-20 | Churchill Capital Corp XI | Huang Rich | 5.13% | SCHEDULE 13G |
| 2026-07-20 | CalciMedica, Inc. | CVI Investments, Inc. | 5.1% | SCHEDULE 13G |
| 2026-07-22 | Liminatus Pharma, Inc. | Samda Biolab Co., Ltd. | 5.1% | SCHEDULE 13G |
| 2026-07-22 | Aetherion Technoligies Inc. | Royce & Associates LP | 5.09% | SCHEDULE 13G |
| 2026-07-24 | Msc Income Fund, Inc. | Sanders Morris Harris LLC | 5.08% | SCHEDULE 13G |
| 2026-07-24 | Cable One, Inc. | DAVENPORT & Co LLC | 5.05% | SCHEDULE 13G |
| 2026-07-24 | Virtus Investment Partners, Inc. | Victory Capital Management, Inc. | 5.03% | SCHEDULE 13G |
| 2026-07-22 | Lsi Industries Inc | Royce & Associates LP | 5% | SCHEDULE 13G |
| 2026-07-22 | enGene Holdings Inc. | Anders Hove | 5% | SCHEDULE 13G |
| 2026-07-24 | One Stop Systems, Inc. | Galkin Vladimir | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.